A detailed history of Legacy Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Legacy Advisors, LLC holds 3,073 shares of BSX stock, worth $276,139. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,073
Previous 2,820 8.97%
Holding current value
$276,139
Previous $217,000 18.43%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.96 - $84.0 $18,458 - $21,252
253 Added 8.97%
3,073 $257,000
Q2 2024

Jul 30, 2024

BUY
$67.33 - $77.71 $189,870 - $219,142
2,820 New
2,820 $217,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Legacy Advisors, LLC Portfolio

Follow Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.